Savara (SVRA) Exchange Rate Effect (2011 - 2026)
Savara's (SVRA) quarterly Exchange Rate Effect came in at $74000.0 in Q1 2026, up 346.67% year-on-year from $16567.2 in Q1 2025, and up 305.56% on a QoQ basis from -$36000.0 in Q4 2025.
Savara (SVRA) Exchange Rate Effect (2011 - 2026) Analysis & Trends
Savara (SVRA) has 12 years of Exchange Rate Effect data on file, last reported at $74000.0 in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 346.67% year-over-year to $74000.0 in Q1 2026; TTM through Mar 2026 was -$173000.0, a 367.57% decrease from a year earlier, with the FY2025 full-year figure at -$277000.0, down 5440.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at $74000.0, up from -$36000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for SVRA reached as high as $120000.0 in Q4 2022 and fell as low as -$145000.0 in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$24470.6 across 5 years, with a median of -$30000.0 in 2025.
- Across the five-year window, Exchange Rate Effect sank 1600.0% in 2025 and surged 346.67% in 2026, its largest moves.
- Year by year, Exchange Rate Effect stood at $120000.0 in 2022, then plunged by 73.33% to $32000.0 in 2023, then plunged by 318.75% to -$70000.0 in 2024, then jumped by 48.57% to -$36000.0 in 2025, then soared by 305.56% to $74000.0 in 2026.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $74000.0 in Q1 2026, -$36000.0 in Q4 2025, and -$74000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 19.32 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 14,631.83 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 74,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Dec 31, 2025 | -36,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Sep 30, 2025 | -74,000.00 |
| Jun 30, 2025 | -137,000.00 |
| Jun 30, 2025 | -137,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Mar 31, 2025 | -30,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Dec 31, 2024 | -70,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |